Skip to main content
. 2020 Nov 12;14:552650. doi: 10.3389/fnins.2020.552650

TABLE 1.

Descriptive data for the sample.

Sample (n = 24)
Mean (SD) or n (%)
Age (years) 49.8 (13.1)
Sex (n)
Male/female 5 (21)/19 (79)
Occupation (n)
Employed/unemployed 14 (58)/10 (42)
Principal comorbidities (n)
Fibromyalgia 5 (21)
Hypertension 4 (17)
Enteric disease 3 (12)
Diabetes mellitus 1 (4)
Other rheumatic disease 1 (4)
None 10 (42)
Drug use (n)
Non-steroidal anti-inflammatory drugs 5 (21)
Antidepressants 2 (8)
Muscle relaxants 2 (8)
Analgesics 3 (11)
None 12 (50)
Symptoms duration (months) 49.21 (68.59)
Symptoms frequencies (n)
Continuous/episodic recurrent 7 (35)/17 (65)
Pain side (n)
Right/left/bilateral 3 (10)/3 (15)/18 (75)
Previous treatment
Physiotherapy 11 (45)
Arthrocentesis 10 (35)
Byte use 16 (65)
DC/TMD Axis I
Myofascial pain 21 (90)
Myalgia 1 (5)
Arthralgia 2 (5)
DC/TMD Axis II
Pain-related disability (n)
Low 9 (37.5)
High 15 (62.5)
Depression (n)
Minimal–mild 16 (66.7)
Moderate–severe 8 (33.3)
Anxiety (n)
Minimal–mild 19 (79)
Moderate–severe 5 (21)
Non-specific physical symptoms (n)
Minimal–mild 13 (54)
Moderate–high 11 (46)
NPRS 6.42 (1.72)
Catastrophizing (n)
Not present 12 (50)
Present 12 (50)
Central sensitization (n)
Subclinical–mild 12 (50)
Moderate–severe 12 (50)

n, number; SD, standard deviation; DC/TMD Axis I and Axis II, Diagnostic Criteria for Temporomandibular Disorders Axis I and Axis II; NPRS, Numeric Pain Rating Scale.